Use of plasma proteins concentrates containing VWF with a high proportion of high molecular weight multimers

US7335634B2 · kind B2 · utility

Assignee

• CSL Behring AG · DE

Inventors

• Olaf Walter · Goldingen, CH
• Hans-Peter Hauser · Marburg, DE

Key dates

• Filing date: May 4, 2005
• Grant date: Feb 26, 2008
• Expiry date: Jan 3, 2026

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P7/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Use of plasma proteins concentrates containing VWF with a high proportion of high molecular weight multimers prevents a bleeding diathesis and reduces pre-, peri- and postoperative blood loss in acquired Von Willebrand syndromes such as in cardiovascular diseases requiring surgical procedures, especially those requiring extracorporeal circulation.